Please wait while we open this resource.
K
Clinical reviews
THE INCIDENCE AND RISK FACTORS OF URINARY TRACT INFECTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS USING SGLT2 INHIBITORS: A REAL-WORLD OBSERVATIONAL STUDY
Department of Pharmaceutical Care, Walailak University, Tha Sala, Nakhon Si Thammarat, Thailand
PDF9 pages1.2 MB
The research focuses on the incidence of urinary tract infections among patients with type 2 diabetes mellitus using SGLT2 inhibitors, specifically dapagliflozin and empagliflozin. It analyzes electronic medication records from a tertiary hospital in Thailand, comparing UTI rates between those treated with SGLT2 inhibitors and those who were not. The findings indicate a significantly higher incidence of UTI in the SGLT2 inhibitor group, with gender, age, and occupation identified as notable risk factors.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology
2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology
METFORMIN―MECHANISMS OF ITS GLYCEMIA-REDUCING EFFECT
Same clinical topic · Endocrinology
SYNDROME OF INAPPROPRIATE ANTIDIURESIS: FROM PATHOPHYSIOLOGY TO MANAGEMENT
Same clinical topic · Endocrinology
GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology
DIAGNOSIS AND MANAGEMENT OF CENTRAL DIABETES INSIPIDUS IN ADULTS
Same clinical topic · Endocrinology
ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology
DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology
OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology